News Home

Is Cara Therapeutics Inc (CARA) a Good Buy in the Healthcare Sector?

Thursday, October 28, 2021 10:40 AM | InvestorsObserver Analysts
Is Cara Therapeutics Inc (CARA) a Good Buy in the Healthcare Sector?

Cara Therapeutics Inc (CARA) is near the top in its sector according to InvestorsObserver. CARA gets an overall rating of 39. That means it scores higher than 39% of stocks. Cara Therapeutics Inc gets a 85 rank in the Healthcare sector. Healthcare is number 8 out of 11 sectors.

Overall Score - 39
CARA has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on CARA!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cara Therapeutics Inc Stock Today?

Cara Therapeutics Inc (CARA) stock is trading at $17.88 as of 10:39 AM on Thursday, Oct 28, a gain of $1.46, or 8.89% from the previous closing price of $16.42. The stock has traded between $15.56 and $17.97 so far today. Volume today is high. So far 787,210 shares have traded compared to average volume of 625,938 shares. Click Here to get the full Stock Report for Cara Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App